Evidence map›Paper›PMID 38704798›Full record

ArticleMycopathologia2024

Genetic Mutations in FKS1 Gene Associated with Acquired Echinocandin Resistance in Candida parapsilosis Complex.

Hazim O Khalifa, Akira Watanabe, Katsuhiko Kamei

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Six-month surveillance ofFrontiers in cellular and infection microbiology · 2026
    Article
  2. Review
  3. Article
  4. Antimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Review
  7. Threats from theMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hazim O KhalifaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, United Arab Emirates University, P.O. Box 1555, Al Ain, United Arab Emirates. hazimkhalifa@uaeu.ac.ae.ORCID http://orcid.org/0000-0001-9861-9693
Akira WatanabeDivision of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan.ORCID http://orcid.org/0000-0003-0496-5945
Katsuhiko KameiDivision of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan.ORCID http://orcid.org/0000-0002-6067-9049

Funding

Japan Agency for Medical Research and Development 21jm0110015Japan Agency for Medical Research and Development JP21fk0108094
6 · The paper itself

Abstract

Candida parapsilosis complex has recently received special attention due to naturally occurring FKS1 polymorphism associated with high minimal inhibitory concentrations for echinocandin and the increase of clonal outbreaks of strains resistant to commonly used antifungals such as fluconazole. Despite the previous fact, little is known about the genetic mechanism associated with echinocandin resistance. Therefore, the present study was designed to investigate the mechanism of acquired echinocandin resistance in C. parapsilosis complex strains. A total of 15 clinical C. parapsilosis complex isolates were sub-cultured for 30 days at a low concentration of micafungin at ½ the lowest MIC value of the tested isolates (0.12 µg/ml). After culturing, all the isolates were checked phenotypically for antifungal resistance and genotypically for echinocandin resistance by checking FKS1 gene hot spot one (HS1) and HS2 mutations. In vitro induction of echinocandin resistance confirmed the rapid development of resistance at low concentration micafungin, with no difference among C. parapsilosis, C. metapsilosis, and C. orthopsilosis in the resistance development. For the first time we identified different FKS1 HS1 and or HS2 mutations responsible for echinocandin resistance such as R658S and L1376F in C. parapsilosis, S656X, R658X, R658T, W1370X, X1371I, V1371X, and R1373X (corresponding to their location in C. parapsilosis) in C. metapsilosis, and L648F and R1366H in C. orthopsilosis. Our results are of significant concern, since the rapid development of resistance may occur clinically after short-term exposure to antifungals as recently described in other fungal species with the potential of untreatable infections.

Indexed as

Antifungal AgentsCandida parapsilosisDrug Resistance, FungalEchinocandinsGlucosyltransferasesCandidiasisFungal ProteinsHumansMicafunginMicrobial Sensitivity TestsMutationMutation, MissenseAntifungal AgentsEchinocandinsFungal Proteinsglucan synthaseGlucosyltransferasesMicafunginAcquired resistanceCandida parapsilosis complexEchinocandinsFKS1 hotspot mutations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.